EP1646623A2 - 5-H-BENZO[D]NAPHTH[2,1-B]AZEPINE DERIVATIVE AS SELECTIVE D1/D5 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF OBESITY AND CNS DISORDERS